UK markets close in 8 hours 23 minutes

Dyne Therapeutics, Inc. (DYN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
32.63-2.75 (-7.77%)
At close: 04:00PM EDT
32.95 +0.32 (+0.98%)
After hours: 07:18PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
-
Operating expenses
Research development
217,765
210,762
142,760
121,308
45,200
-
Selling general and administrative
48,090
31,400
28,202
28,717
13,447
-
Total operating expenses
265,855
242,162
170,962
150,025
58,647
-
Operating income or loss
-265,855
-242,162
-170,962
-150,025
-58,647
-
Interest expense
-
-
-
0
396
0
Total other income/expenses net
-694
-1,416
-54
-8
-450
-
Income before tax
-257,399
-235,937
-168,099
-149,291
-59,437
-
Income from continuing operations
-257,399
-235,937
-168,099
-149,291
-59,437
-
Net income
-257,399
-235,937
-168,099
-149,291
-59,437
-
Net income available to common shareholders
-257,399
-235,937
-168,099
-149,291
-59,437
-
Basic EPS
-3.59
-
-3.23
-2.93
-4.13
-1.16
Diluted EPS
-3.59
-
-3.23
-2.93
-4.13
-1.16
Basic average shares
57,538
-
51,976
50,895
14,396
12,818
Diluted average shares
57,538
-
51,976
50,895
14,396
12,818